POINT today announced that it has entered into a definitive agreement with Bach Biosciences, a company commercializing the research of William Bachovchin, Professor of Developmental, Chemical and Molecular Biology at Tufts University...
POINT Biopharma Inc. announces its CEO Dr. Joe McCann will present at the 2020 BIOInvestor Forum.
POINT Biopharma Inc. (POINT), a radiopharmaceutical company dedicated to bringing the many benefits...
POINT Biopharma Inc. (POINT), a radiopharmaceutical company dedicated to bringing the many benefits ...
ITM Isotopen Technologien München AG (ITM), a biotechnology and radiopharmaceutical group of ...